MYOK Insider Trading Activity and SEC Form 4 Filings
MYOK insider trading summary
No open-market insider purchases or sales of MyoKardia, Inc. (MYOK) have been reported on SEC Form 4 in the past 12 months.
Latest MYOK insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 2, 2020 | Anastasios Gianakakos | President and CEO | Sell | $166K (1,776 @ $93.55) |
| Jul 2, 2020 | Anastasios Gianakakos | President and CEO | Sell | $304K (3,224 @ $94.22) |
| Jun 30, 2020 | Mary B Cranston | Director | Sell | $2.1M (21,329 @ $96.59) |
| Jun 30, 2020 | Mary B Cranston | Director | Sell | $29K (300 @ $97.25) |
| Jun 29, 2020 | Mary B Cranston | Director | Sell | $37K (371 @ $98.68) |
| Jun 2, 2020 | Anastasios Gianakakos | President and CEO | Sell | $196K (1,885 @ $103.77) |
| Jun 2, 2020 | Anastasios Gianakakos | President and CEO | Sell | $33K (319 @ $104.64) |
| Jun 2, 2020 | Anastasios Gianakakos | President and CEO | Sell | $81K (800 @ $101.72) |
| Jun 2, 2020 | Anastasios Gianakakos | President and CEO | Sell | $60K (600 @ $100.59) |
| Jun 2, 2020 | Anastasios Gianakakos | President and CEO | Sell | $143K (1,396 @ $102.78) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.